Celadon Pharmaceuticals (CEL) Stock Chart & Stock Price History → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free CEL Stock Alerts GBX 100 -2.50 (-2.44%) (As of 07:39 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlines Celadon Pharmaceuticals Stock Price Performance5 Day Performance-1.48%1 Month Performance+5.26%3 Month Performance-7.60%6 Month Performance+22.70%Year-To-Date Performance-13.04%1 Year Performance-28.57% Receive CEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The Tomorrow InvestorThe Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest CEL Stock Chart for Tuesday, May, 14, 2024 CEL Chart by TradingView Celadon Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024GBX 102.50GBX 105+2.44%GBX 107GBX 1003,459 shs£67.42 million05/10/2024GBX 101.50GBX 100-1.48%GBX 105GBX 10036,902 shs£64.21 million05/09/2024GBX 101.50GBX 101.50GBX 105GBX 984,819 shs£65.17 million05/08/2024GBX 98GBX 101.50+3.57%GBX 105GBX 98.163,209 shs£65.17 million05/07/2024GBX 101.49GBX 98-3.44%GBX 105GBX 987,401 shs£62.93 million05/06/2024GBX 101.50GBX 101.49-0.01%GBX 105GBX 9811,347 shs£65.17 million Get the Latest News and Ratings for CEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024GBX 101.50GBX 101.50GBX 105GBX 9811,347 shs£65.17 million05/02/2024GBX 100GBX 101.50+1.50%GBX 101.71GBX 101.501,180 shs£65.17 million05/01/2024GBX 98GBX 100+2.04%GBX 105GBX 9638,885 shs£64.21 million04/30/2024GBX 102.50GBX 98-4.39%GBX 105GBX 968,892 shs£62.93 million04/29/2024GBX 102.50GBX 102.50GBX 105GBX 1009,637 shs£65.82 million04/26/2024GBX 105GBX 102.50-2.38%GBX 112GBX 101.2043,443 shs£65.82 million04/25/2024GBX 110GBX 105-4.55%GBX 110GBX 10026,117 shs£67.42 million04/24/2024GBX 115GBX 110-4.35%GBX 120GBX 105100,432 shs£70.63 million04/23/2024GBX 115GBX 115GBX 120GBX 11090,868 shs£73.84 million04/22/2024GBX 115GBX 115GBX 122.50GBX 11097,517 shs£73.84 million04/19/2024GBX 116.66GBX 120+2.86%GBX 120GBX 110157,151 shs£77.05 million04/18/2024GBX 110GBX 116.66+6.05%GBX 120GBX 105115,466 shs£74.91 million04/17/2024GBX 110GBX 110GBX 115GBX 108.31129,480 shs£70.63 million04/16/2024GBX 107.50GBX 110+2.33%GBX 114GBX 105139,400 shs£70.63 million04/15/2024GBX 95GBX 107.50+13.16%GBX 110GBX 90156,526 shs£69.03 million04/12/2024GBX 100GBX 95-5.00%GBX 100GBX 90100,984 shs£61.00 million04/11/2024GBX 87.50GBX 100+14.29%GBX 100GBX 85206,628 shs£64.21 million04/10/2024GBX 88.90GBX 87.50-1.57%GBX 91.80GBX 854,248 shs£56.18 million04/09/2024GBX 88.40GBX 88.90+0.57%GBX 90GBX 85.653,812 shs£57.08 million04/08/2024GBX 87.50GBX 88.40+1.03%GBX 95GBX 85141,052 shs£56.76 million04/05/2024GBX 88.80GBX 89+0.23%GBX 94GBX 8561,442 shs£57.15 million04/04/2024GBX 82.50GBX 88.80+7.64%GBX 90GBX 81.5079,768 shs£57.02 million04/03/2024GBX 78.50GBX 82.50+5.10%GBX 83.50GBX 7570,946 shs£52.97 million04/02/2024GBX 84GBX 78.50-6.55%GBX 86.80GBX 78.50178,593 shs£50.41 million04/01/2024GBX 84GBX 84GBX 86.50GBX 806,429 shs£53.94 million03/29/2024GBX 84GBX 84GBX 86.50GBX 806,429 shs£53.94 million03/28/2024GBX 82.50GBX 84+1.82%GBX 86.50GBX 806,429 shs£53.94 million03/27/2024GBX 82.50GBX 82.50GBX 85GBX 806,362 shs£52.97 million03/26/2024GBX 90GBX 82.50-8.33%GBX 90GBX 8035,910 shs£52.97 million03/25/2024GBX 87.50GBX 90+2.86%GBX 95GBX 85.1020,916 shs£57.79 million03/22/2024GBX 92.50GBX 87.50-5.41%GBX 95GBX 87.5026,127 shs£56.18 million03/21/2024GBX 92.50GBX 92.50GBX 95GBX 92.501,257 shs£59.39 million03/20/2024GBX 92.50GBX 92.50GBX 95GBX 901,931 shs£59.39 million03/19/2024GBX 97.50GBX 92.50-5.13%GBX 100GBX 89.3632,984 shs£59.39 millionWhat’s Really Next for America… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now.03/18/2024GBX 100GBX 97.50-2.50%GBX 105GBX 95403,284 shs£62.61 million03/15/2024GBX 100GBX 100GBX 103GBX 96.5518,041 shs£64.21 million03/14/2024GBX 105GBX 100-4.76%GBX 103GBX 10066 shs£64.21 million03/13/2024GBX 100GBX 105+5.00%GBX 105GBX 103784 shs£67.42 million03/12/2024GBX 95GBX 100+5.26%GBX 105GBX 951,064 shs£64.21 million03/11/2024GBX 104GBX 95-8.65%GBX 97GBX 954,187 shs£61.00 million03/08/2024GBX 102.50GBX 104+1.46%GBX 105GBX 1042,085 shs£66.78 million03/07/2024GBX 97.50GBX 102.50+5.13%GBX 105GBX 10016,912 shs£65.82 million03/06/2024GBX 97.50GBX 97.50GBX 100GBX 97.501,309 shs£62.61 million03/05/2024GBX 100GBX 97.50-2.50%GBX 105GBX 952,297 shs£62.61 million03/04/2024GBX 100GBX 100GBX 105GBX 938,141 shs£64.21 million03/01/2024GBX 100GBX 103+3.00%GBX 105GBX 954,049 shs£66.14 million02/29/2024GBX 107.50GBX 100-6.98%GBX 110GBX 9634,364 shs£64.21 million02/28/2024GBX 106GBX 107.50+1.42%GBX 110GBX 1053,028 shs£69.03 million02/27/2024GBX 110GBX 106-3.64%GBX 115GBX 10521,636 shs£68.06 million02/26/2024GBX 110GBX 110GBX 115GBX 10544,689 shs£70.63 million02/23/2024GBX 110GBX 111.98+1.80%GBX 115GBX 106.346,187 shs£71.90 million02/22/2024GBX 111.40GBX 110-1.26%GBX 115GBX 1058,111 shs£70.63 million02/21/2024GBX 115GBX 111.40-3.13%GBX 115GBX 106.3410,188 shs£71.53 million02/20/2024GBX 110GBX 115+4.55%GBX 115GBX 11013,448 shs£73.84 million02/19/2024GBX 112.50GBX 110-2.22%GBX 118.80GBX 11030,425 shs£70.63 million02/16/2024GBX 105.50GBX 112.50+6.64%GBX 115GBX 1057,155 shs£72.24 million02/15/2024GBX 108.22GBX 105.50-2.51%GBX 115GBX 105.5012,078 shs£67.74 million02/14/2024GBX 115GBX 108.22-5.90%GBX 117GBX 10560,592 shs£69.49 million02/13/2024GBX 115GBX 115GBX 120GBX 10527,664 shs£73.84 million Related Companies: ECO Animal Health Group Stock Chart Venture Life Group Stock Chart Animalcare Group Stock Chart Allergy Therapeutics Stock Chart Beximco Pharmaceuticals Stock Chart Alliance Pharma Stock Chart INSPECS Group Stock Chart Redx Pharma Stock Chart e-therapeutics Stock Chart Poolbeg Pharma Stock Chart Receive CEL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:CEL) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportGuard Against the Coming Financial UpheavalPorter & CompanyDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsThis 1 Biotech Stock has been shocking the marketsHuge AlertsElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celadon Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.